Strong Buy
Average AnalystStrong Buy
Top AnalystSlightly Bullish
Stock Target AdvisorBuy
Average UserUSD 555.47
-2.45 (-0.44)%
N/A
0.82M
USD 651.71(+17.33%)
Symbol | Name | Exchange | TMO's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
Putnam Biorevolution ETF | NYE | 6.93 % | 0.70 % | -0.06 (-0.18%) | USD5.57M |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The company has under performed its peers on annual average total returns in the past 5 years.
This stock has shown below median dividend growth in the previous 5 years compared to its sector.